Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients

Coronary Artery Disease

Volumn 7, Issue 5, 1996, Pages 371-375

  Suzuki, Toru ^a   Yokota, Hiromitsu ^a   Yamazaki, Tsutomu ^a,b   Kitamura, Kiyoshi ^a   Yamaoki, Kazuhide ^a   Nagai, Ryozo ^a,c   Yazaki, Yoshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

angiotensin converting enzyme polymorphism; coronary heart disease

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; JAPAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029831367     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199605000-00007     Document Type: Article

References (25)

1. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al.: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994, 90:669-676.
2. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
3. Cambien F: The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994, 47:94-101.
4. Rigat B, Hubert C, Alhenc GF, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
5. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993, 341:991-992.
6. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993, 44:298-301.
7. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
8. Ohishi M, Rakugi H, Ogihara T: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 331:1097-1098.
9. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994, 90:2622-2628.
10. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994, 267:1107-1111.
11. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
12. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al.: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994, 12:955-957.
13. Lee E: Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 1994, 37:212-214.
14. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994, 7:759-762.
15. Gu XX, Spaepen M, Guo C, Fagard R, Amery A, Lijnen P, et al.: Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994, 8:683-685.
16. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al.: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993, 191:399-404.
17. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, La Motte F, et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 1995, 332:706-711.
18. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995, 91:2120-2124.
19. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al.: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994, 90:2199-2202.
20. Humphries JO, Kuller L, Ross RS, Friesinger GC, Page EE: Natural history of ischaemic heart disease in relation to arteriographic findings: a twelve year study of 224 patients. Circulation 1974, 49:489-497.
21. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1992, 20:1433.
22. Nakahara K, Nishimura H, Kuro-o M, Takewaki S, Iwase M, Ohkubo A, et al.: Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem Biophys Res Commun 1992, 184:811-818.
23. Campbell-Boswell M, Robertson AL: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981, 35:265-276.
24. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995, 345:1013-1016.
25. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, et al.: Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993, 73:1000-1012.